# NRG Oncology

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/nrg-oncology/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| OpenAlex ID | https://openalex.org/F4320317868 |
| ROR ID | https://ror.org/050draa26 |
| Works | 477 |

## Funder papers

- [Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial](https://scholariq.org/papers/overall-survival-with-maintenance-olaparib-at-a-7-year-follow-up-in-patients/)
- [Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/niraparib-first-line-maintenance-therapy-in-patients-with-newly-diagnosed/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.